{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:01:38Z","timestamp":1762808498385,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12013-017-0791-8","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T01:02:31Z","timestamp":1490749351000},"page":"91-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations"],"prefix":"10.1007","volume":"76","author":[{"given":"Bagavathy Shanmugam","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvaiyarasan","family":"Suvaithenamudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Abdulkader","family":"Akbarsha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subbiah","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"791_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-6997(24)01340-1","volume":"49","author":"JH Lin","year":"1997","unstructured":"Lin, J. H., & Lu, A. Y. (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacological Reviews, 49, 403\u2013449.","journal-title":"Pharmacological Reviews"},{"issue":"2","key":"791_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1582-4934.2002.tb00186.x","volume":"6","author":"R Zuber","year":"2002","unstructured":"Zuber, R., Anzenbacherov\u00e1, E., & Anzenbacher, P. (2002). Cytochromes P450 and experimental models of drug metabolism. Journal of Cellular and Molecular Medicine, 6(2), 189\u2013198.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"791_CR3","doi-asserted-by":"publisher","first-page":"37739","DOI":"10.1074\/jbc.R100033200","volume":"276","author":"W Xie","year":"2001","unstructured":"Xie, W., & Evans, R. M. (2001). Orphan nuclear receptors: The exotics of xenobiotics. Journal of Biological Chemistry, 276, 37739\u201337742.","journal-title":"Journal of Biological Chemistry"},{"key":"791_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2.6.875","volume":"2","author":"M Martignoni","year":"2006","unstructured":"Martignoni, M., Groothuis, G. M., & de Kanter, R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opinion on Drug Metabolism and Toxicology, 2, 875\u2013894.","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"key":"791_CR5","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.1021\/jp800311c","volume":"112","author":"J Skopalik","year":"2008","unstructured":"Skopalik, J., Anzenbacher, P., & Otyepka, M. (2008). Flexibility of human cytochromes P450: Molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. Journal of Physical Chemistry B, 112, 8165\u20138173.","journal-title":"Journal of Physical Chemistry B"},{"key":"791_CR6","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1021\/jm801005m","volume":"51","author":"J Hritz","year":"2008","unstructured":"Hritz, J., de Ruiter, A., & Oostenbrink, C. (2008). Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: A combined approach of molecular dynamics and ligand docking. Journal of Medicinal Chemistry, 51, 7469\u20137477.","journal-title":"Journal of Medicinal Chemistry"},{"key":"791_CR7","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1016\/j.ejmech.2010.07.055","volume":"45","author":"MC Rosales- Hern\u00e1ndez","year":"2010","unstructured":"Rosales- Hern\u00e1ndez, M. C., Mendieta-Wejebem, J. E., Trujillo-Ferrara, J. G., & Correa-Basurto, J. (2010). Homology modeling and molecular dynamics of CYP1A1 and CYP281 to explore the metabolism of aryl derivatives by docking and experimental assays. European Journal of Medicinal Chemistry, 45, 4845\u20134855.","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"8","key":"791_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jmr.2537","volume":"29","author":"SS Kesharwani","year":"2016","unstructured":"Kesharwani, S. S., Nandekar, P. P., Pragyan, P., Rathod, V., & Sangamwar, A. T. (2016). Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: An integrated approach employing molecular docking and molecular dynamics simulations. Journal of Molecular Recognition, 29(8), 370\u2013390.","journal-title":"Journal of Molecular Recognition"},{"issue":"7","key":"791_CR9","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1039\/C5MB00118H","volume":"11","author":"G Mukherjee","year":"2015","unstructured":"Mukherjee, G., Lal Gupta, P., & Jayaram, B. (2015). Predicting the binding modes and sites of metabolism of xenobiotics. Molecular Biosystems, 11(7), 1914\u20131924.","journal-title":"Molecular Biosystems"},{"issue":"4","key":"791_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1021\/tx025674x","volume":"16","author":"JM Hutzler","year":"2003","unstructured":"Hutzler, J. M., Walker, G. S., & Wienkers, L. C. (2003). Inhibition of cytochrome P450 2D6: Structure-activity studies using a series of quinidine and quinine analogues. Chemical Researchin Toxicology, 16(4), 450\u2013459.","journal-title":"Chemical Researchin Toxicology"},{"issue":"1","key":"791_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0209578","volume":"2","author":"J Venhorst","year":"2003","unstructured":"Venhorst, J., Ter Laak, A. M., Commandeur, J. N., Funae, Y., Hiroi, T., & Vermeulen, N. P. (2003). Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. Journal of Medicinal Chemistry, 2(1), 74\u201386. 46.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"10","key":"791_CR12","first-page":"1130","volume":"25","author":"N Chauret","year":"1997","unstructured":"Chauret, N., Gauthier, A., Martin, J., & Nicoll-Griffith, D. A. (1997). In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition, 25(10), 1130\u20131136.","journal-title":"Drug Metabolism and Disposition"},{"key":"791_CR13","doi-asserted-by":"publisher","first-page":"e63335","DOI":"10.1371\/journal.pone.0063335","volume":"8","author":"GH Edmund","year":"2013","unstructured":"Edmund, G. H., Lewis, D. F., & Howlin, B. J. (2013). Modelling species selectivity in rat and human cytochrome P450 2D enzymes. PLoS One, 8, e63335.","journal-title":"PLoS One"},{"issue":"11","key":"791_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/00498250110065603","volume":"31","author":"MS Ching","year":"2001","unstructured":"Ching, M. S., Blake, C. L., Malek, N. A., Angus, P. W., & Ghabrial, H. (2001). Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine. Xenobiotica, 31(11), 757\u2013767.","journal-title":"Xenobiotica"},{"issue":"12","key":"791_CR15","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1177\/0091270006293753","volume":"46","author":"RL Walsky","year":"2006","unstructured":"Walsky, R. L., Astuccio, A. V., & Obach, R. S. (2006). Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. The Journal of Clinical Pharmacology, 46(12), 1426\u20131438.","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"4","key":"791_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/cc2183","volume":"7","author":"A Trampuz","year":"2003","unstructured":"Trampuz, A., Jereb, M., Muzlovic, I., & Prabhu, R. M. (2003). Clinical review: Severe malaria. Critical Care., 7(4), 315\u2013323.","journal-title":"Critical Care."},{"issue":"5","key":"791_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjp.0707238","volume":"151","author":"AJ Thompson","year":"2007","unstructured":"Thompson, A. J., Lochner, M., & Lummis, S. C. (2007). The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors. British Journal of Pharmacology, 151(5), 666\u2013677.","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"791_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/bjp.2008.34","volume":"153","author":"AJ Thompson","year":"2008","unstructured":"Thompson, A. J., & Lummis, S. C. (2008). Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptors. British Journal of Pharmacology, 153(8), 1686\u20131696.","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"791_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/mol.63.5.1051","volume":"63","author":"JA S\u0103nchez-Chapula","year":"2003","unstructured":"S\u0103nchez-Chapula, J. A., Ferrer, T., Navarro-Polanco, R. A., & Sanguinetti, M. C. (2003). Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. Molecular Pharmacology, 63(5), 1051\u20131058.","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"791_CR20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ijc.10054","volume":"10","author":"S Mukanganyama","year":"2002","unstructured":"Mukanganyama, S., Widersten, M., Naik, Y. S., Mannervik, B., & Hasler, J. A. (2002). Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. International Journal of Cancer, 10(5), 700\u2013705. 97.","journal-title":"International Journal of Cancer"},{"key":"791_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., Van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29, 845\u2013854.","journal-title":"Bioinformatics"},{"key":"791_CR22","doi-asserted-by":"publisher","first-page":"D301","DOI":"10.1093\/nar\/gkl971","volume":"35","author":"H Berman","year":"2007","unstructured":"Berman, H., Henrick, K., Nakamura, H., & Markley, J. L. (2007). The worldwide Protein Data Bank (wwPDB): Ensuring a single, uniform archive of PDB data. Nucleic Acids Research, 35, D301\u2013D303.","journal-title":"Nucleic Acids Research"},{"key":"791_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1039\/C6MB00210B","volume":"21","author":"BS Karthikeyan","year":"2016","unstructured":"Karthikeyan, B. S., Akbarsha, M. A., & Parthasarathy, S. (2016). Network analysis and cross species comparison of protein-protein interaction networks of human, mouse and rat cytochrome P450 proteins that degrade xenobiotics. Molecular Biosystems, 21, 2119\u20132134. 12.","journal-title":"Molecular Biosystems"},{"key":"791_CR24","first-page":"bar009","volume":"29","author":"M Magrane","year":"2011","unstructured":"Magrane, M., & Consortium, U. (2011). UniProt knowledgebase: A hub of integrated protein data. Database (Oxford), 29, bar009.","journal-title":"Database (Oxford)"},{"key":"791_CR25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1124\/mol.111.074427","volume":"80","author":"MB Shah","year":"2011","unstructured":"Shah, M. B., Pascual, J., Zhang, Q., Stout, C. D., & Halpert, J. R. (2011). Stuctures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl) pyridine: Insight into inhibitor binding and rearrangement of active site side chains. Molecular Pharmacology, 80, 1047\u20131055.","journal-title":"Molecular Pharmacology"},{"issue":"Web Server issu","key":"791_CR26","doi-asserted-by":"publisher","first-page":"W413","DOI":"10.1093\/nar\/gkp281","volume":"37","author":"M Hernandez","year":"2009","unstructured":"Hernandez, M., Ghersi, D., & Sanchez, R. (2009). SITEHOUND-web: A server for ligand binding site identification in protein structures. Nucleic Acids Research, 37(Web Server issue), W413\u2013W416.","journal-title":"Nucleic Acids Research"},{"key":"791_CR27","doi-asserted-by":"publisher","first-page":"14348","DOI":"10.1074\/jbc.M611692200","volume":"282","author":"S Sansen","year":"2007","unstructured":"Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2007). Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. Journal of Biological Chemistry, 282, 14348\u201314355.","journal-title":"Journal of Biological Chemistry"},{"key":"791_CR28","doi-asserted-by":"publisher","first-page":"12932","DOI":"10.1074\/jbc.M113.452953","volume":"288","author":"AA Walsh","year":"2013","unstructured":"Walsh, A. A., Szklarz, G. D., & Scott, E. E. (2013). Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. Journal of Biological Chemistry, 288, 12932\u201312943.","journal-title":"Journal of Biological Chemistry"},{"key":"791_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006). Novel procedure for modeling ligand\/ receptor induced fit effects. Journal of Medicinal Chemistry, 49, 534\u2013553.","journal-title":"Journal of Medicinal Chemistry"},{"key":"791_CR30","unstructured":"Gunsteren, W. F. V., Billeter, S. R., Eising, A. A., Hunenberger, P. H., Kruger, P. K., Mark, A. E., Scott, W. R. P., Tironi, I. G. (1996). Biomolecular stimulation: The {GROMOS96} manual and user guide. Verlag der Fachvereine, Zurich, 1\u20131024."},{"key":"791_CR31","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52, 7182\u20137190.","journal-title":"Journal of Applied Physics"},{"key":"791_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica D Biological Crystallography, 60, 1355\u20131363.","journal-title":"Acta Crystallographica D Biological Crystallography"},{"key":"791_CR33","unstructured":"Williams, T., & Kelley, C. (2011). Gnuplot. An Interactive Plotting Program Available at http:\/\/www.gnuplot.info\/"},{"key":"791_CR34","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1074\/jbc.M110.204420","volume":"286","author":"A Wang","year":"2011","unstructured":"Wang, A., Savas, U., Stout, C. D., & Johnson, E. F. (2011). Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1. Journal of Biological Chemistry, 286, 5736\u20135743.","journal-title":"Journal of Biological Chemistry"},{"key":"791_CR35","doi-asserted-by":"publisher","first-page":"33698","DOI":"10.1074\/jbc.M805999200","volume":"283","author":"PR Porubsky","year":"2008","unstructured":"Porubsky, P. R., Meneely, K. M., & Scott, E. E. (2008). Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. Journal of Biological Chemistry, 283, 33698\u201333707.","journal-title":"Journal of Biological Chemistry"},{"key":"791_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1517\/17425250902967648","volume":"5","author":"YY Zhang","year":"2009","unstructured":"Zhang, Y. Y., & Yang, L. (2009). Interactions between human cytochrome P450 enzymes and steroids: Physiological and pharmacological implications. Expert Opinion on Drug Metabolism and Toxicology, 5, 621\u2013629.","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"issue":"39","key":"791_CR37","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1021\/ja0524604","volume":"127","author":"T Jovanovic","year":"2005","unstructured":"Jovanovic, T., Farid, R., Friesner, R. A., & McDermott, A. E. (2005). Thermal equilibrium of high- and low-spin forms of cytochrome P450 BM-3: Repositioning of the substrate? Journal of the American Chemical Society, 127(39), 13548\u201313552.","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"791_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.24985","volume":"84","author":"L Capoferri","year":"2016","unstructured":"Capoferri, L., Leth, R., ter Haar, E., Mohanty, A. K., Grootenhuis, P. D., Vottero, E., Commandeur, J. N., Vermeulen, N. P., J\u00f8rgensen, F. S., Olsen, L., & Geerke, D. P. (2016). Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations. Proteins, 84(3), 383\u2013396.","journal-title":"Proteins"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-017-0791-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-017-0791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-017-0791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T19:04:46Z","timestamp":1750187086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-017-0791-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1007\/s12013-017-0791-8","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"type":"print","value":"1085-9195"},{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2017,3,29]]},"assertion":[{"value":"21 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}